- Patent Title: Heterocyclic modulators of HIF activity for treatment of disease
-
Application No.: US15285177Application Date: 2016-10-04
-
Publication No.: US10208059B2Publication Date: 2019-02-19
- Inventor: Philip Jones , Maria Emilia Di Francesco , Alessia Petrocchi , Christopher L. Carroll , Joe Marszalek , Barbara Czako , Ryan Johnson , Jay Theroff
- Applicant: Board of Regents, University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agent Dennis A. Bennett; Cynthia Hathaway; John Desper
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D495/04 ; C07D413/04 ; C07D417/14 ; C07D417/04 ; A61K45/06 ; A61K31/496 ; A61K31/454 ; C07D471/04 ; C07D513/04 ; A61K31/4245 ; A61K31/437 ; A61K31/4439 ; A61K31/4545 ; A61K31/519 ; A61K31/5377 ; A61K31/541 ; C07D405/14 ; A61K31/427 ; A61K31/4709 ; A61K31/497 ; A61K31/506
Abstract:
The present invention relates to compounds and methods which may be useful as inhibitors of HIF pathway activity for the treatment or prevention of cancer and other hypoxia-mediated diseases.
Public/Granted literature
- US20170121342A1 HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE Public/Granted day:2017-05-04
Information query
